Regulatory Responsibilities. ELITE will, at its own cost and expense, continue to own and maintain the applicable Regulatory Approvals necessary to market the Products in the Territory. ELITE shall be responsible for all regulatory and safety reporting requirements associated with ownership of the Regulatory Approval, including, without limitation, adverse event reports, annual reports mandated by the applicable Laws in the Territory. Additionally, ELITE shall be responsible for complying with applicable Laws to appropriately categorize and report changes to the FDA, including without limitation, amendments, supplements, and annual reports. All communications by ELITE with the FDA relating to the Products as marketed in the Territory shall be promptly provided in writing to LANNETT, and ELITE shall promptly provide to LANNETT copies of all documents sent to or received from the FDA regarding the Products.
Appears in 4 contracts
Samples: License, Supply and Distribution Agreement (Elite Pharmaceuticals Inc /Nv/), License, Supply and Distribution Agreement (Elite Pharmaceuticals Inc /Nv/), License, Supply and Distribution Agreement (Elite Pharmaceuticals Inc /Nv/)